1) 1 period diabetic retinopathy
1期糖尿病视网膜病变
2) Early Diabetic Retinopathy
早期糖尿病视网膜病变
1.
Detection of serum cytokines in patients with early diabetic retinopathy
早期糖尿病视网膜病变患者血清相关细胞因子的检测
3) early proliferlative diabetic retinopathy
早期增殖期糖尿病视网膜病变
5) Diabetic retinopathy
糖尿病视网膜病变
1.
Treatment of diabetic retinopathy by combination of kallidinogenase and compound Danshen dripping pills;
胰激肽原酶与复方丹参滴丸联合治疗糖尿病视网膜病变的临床观察
2.
Chinese drugs combine with Duobeisi for diabetic retinopathy;
中药联合多贝斯治疗糖尿病视网膜病变临床研究
3.
Combined therapy for diabetic retinopathy after cataract extraction;
白内障术后糖尿病视网膜病变的综合治疗
6) diabetic retinopathy
糖尿病性视网膜病变
1.
Analysis of effects of laser photocoagulation for diabetic retinopathy;
激光光凝治疗糖尿病性视网膜病变疗效分析
2.
Susceptibility genes for diabetic retinopathy;
糖尿病性视网膜病变的易感基因(英文)
3.
Analysis of anterior ischemic optic neuro-pathy in patients with diabetic retinopathy;
糖尿病性视网膜病变患者前部缺血性视神经病变临床分析
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条